Northwestern University Feinberg School of Medicine
Skip to main content

Northwestern Cancer Prevention Consortium

Please visit nucancerprevention.org for updated information regarding the Northwestern Cancer Prevention Consortium and its clinical trials.

For Participants


  • ClinicalTrials.gov: A registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.
  • NCPC Clinical Trials:
    • NWU20-01-03 - ROLE OF LISINOPRIL IN PREVENTING THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): RELIEF-NAFLD (Currently Recruiting).
    • NWU20-02-01 - SURGICAL WINDOW OF OPPORTUNITY STUDY OF MEGESTROL ACETATE COMPARED WITH MEGESTROL ACETATE AND METFORMIN FOR ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA (Currently Recruiting).
    • NWU20-02-02 - A RANDOMIZED AND PLACEBO-CONTROLLED PHASE II TRIAL TARGETING DOMINANT-NEGATIVE MISSENSE MUTANT P53 BY ATORVASTATIN FOR REDUCING THE RISK OF LONGSTANDING ULCERATIVE COLITIS-ASSOCIATED CANCER (Currently Recruiting).
    • NWU20-04-01 - METFORMIN FOR CHEMOPREVENTION OF LUNG CANCER IN HIGH-RISK OVERWEIGHT OR OBESE INDIVIDUALS (Currently Recruiting).
    • INT21-05-01 - A PHASE IIB CLINICAL TRIAL OF THE MULTITARGETED RECOMBINANT ADENOVIRUS 5 (CEA/MUC1/BRACHYURY) VACCINES (TRI- AD5) AND IL-15 SUPERAGONIST N-803 IN LYNCH SYNDROME (Currently Recruiting).

For Scientists


Please email NCPC@northwestern.edu for information about chemoprevention trials.

Research articles:

These studies are funded by a contract from the National Cancer Institute, National Institutes of Health and the U.S. Department of Health and Human Services.

For more information, review the contact information below.

 Contact Us

Seema Khan, MD

s-khan2@northwestern.edu
Consortium Principal Investigator
Northwestern University
303 E. Superior, Suite 4-111
Chicago, IL 60611
Phone: 312-503-4236

 

NCPC Administration

ncpc@northwestern.edu

 

twitter